JP2024534936A5 - - Google Patents
Info
- Publication number
- JP2024534936A5 JP2024534936A5 JP2024514662A JP2024514662A JP2024534936A5 JP 2024534936 A5 JP2024534936 A5 JP 2024534936A5 JP 2024514662 A JP2024514662 A JP 2024514662A JP 2024514662 A JP2024514662 A JP 2024514662A JP 2024534936 A5 JP2024534936 A5 JP 2024534936A5
- Authority
- JP
- Japan
- Prior art keywords
- weeks
- years
- approximately
- bischoline
- tetrathiomolybdate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163241441P | 2021-09-07 | 2021-09-07 | |
| US63/241,441 | 2021-09-07 | ||
| PCT/US2022/042664 WO2023038909A1 (en) | 2021-09-07 | 2022-09-06 | Methods of treating copper metabolism-associated diseases or disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534936A JP2024534936A (ja) | 2024-09-26 |
| JP2024534936A5 true JP2024534936A5 (https=) | 2025-09-17 |
Family
ID=85507733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024514662A Pending JP2024534936A (ja) | 2021-09-07 | 2022-09-06 | 銅代謝関連疾患又は障害を治療する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240342127A1 (https=) |
| EP (1) | EP4398896A4 (https=) |
| JP (1) | JP2024534936A (https=) |
| CN (1) | CN117915907A (https=) |
| CA (1) | CA3230084A1 (https=) |
| WO (1) | WO2023038909A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023023199A1 (en) * | 2021-08-17 | 2023-02-23 | Alexion Pharmaceuticals, Inc. | Methods of treating copper metabolism-associated diseases or disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11147887B2 (en) * | 2014-12-17 | 2021-10-19 | Fundación Para La Investigación Mèdica Aplicada | Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson disease |
| US11419832B2 (en) * | 2017-12-04 | 2022-08-23 | Alexion Pharmaceuticals, Inc. | Bis-choline tetrathiomolybdate for treating Wilson Disease |
| EP3880809A4 (en) * | 2018-11-16 | 2023-01-11 | Encoded Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF WILSON'S DISEASE |
| EP4243806A1 (en) * | 2020-11-13 | 2023-09-20 | Alexion Pharmaceuticals, Inc. | Methods of treating copper metabolism-associated diseases or disorders |
| WO2023023199A1 (en) * | 2021-08-17 | 2023-02-23 | Alexion Pharmaceuticals, Inc. | Methods of treating copper metabolism-associated diseases or disorders |
-
2022
- 2022-09-06 WO PCT/US2022/042664 patent/WO2023038909A1/en not_active Ceased
- 2022-09-06 US US18/685,127 patent/US20240342127A1/en active Pending
- 2022-09-06 EP EP22867964.3A patent/EP4398896A4/en active Pending
- 2022-09-06 CN CN202280061276.3A patent/CN117915907A/zh active Pending
- 2022-09-06 JP JP2024514662A patent/JP2024534936A/ja active Pending
- 2022-09-06 CA CA3230084A patent/CA3230084A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250205213A1 (en) | Method of treatment with tradipitant | |
| JP2021502403A (ja) | 遺伝性てんかん性障害の処置に使用するガナキソロン | |
| EP3706739B1 (en) | Use of riluzole prodrugs to treat ataxias | |
| Vitkov et al. | Candida‐induced stomatopyrosis and its relation to diabetes mellitus | |
| AU2021392090A1 (en) | Cannabidiol for the treatment of refractory seizures | |
| US20230098944A1 (en) | Method of decreasing amyloid beta monomer levels in patients with cognitive decline | |
| Chaitanya et al. | A Meta-Analysis on the Efficacy of Zinc in Oral Mucositis during Cancer Chemo and/or Radiotherapy—An Evidence-Based Approach | |
| JP2024534936A5 (https=) | ||
| WO2007046347A1 (ja) | 筋萎縮性側索硬化症患者の運動神経保護用医薬 | |
| CN102143686A (zh) | 用4-氨基吡啶持续治疗脱髓鞘病患者 | |
| JP2023549814A5 (https=) | ||
| Servais et al. | FIREFISH part 2: efficacy and safety of risdiplam (RG7916) in infants with Type 1 spinal muscular atrophy (SMA) | |
| JP2024532131A5 (https=) | ||
| Acharya et al. | Diagnosis and management of pseudomembranous candidiasis | |
| JP2022507528A5 (https=) | ||
| CN120051284A (zh) | 用于治疗早期阿尔茨海默病的方法 | |
| Primhak et al. | The bronchoprotective effect of inhaled salmeterol in preschool children: a dose-ranging study | |
| JP7117438B1 (ja) | アレルギー性結膜炎治療剤 | |
| US20200061103A1 (en) | Inhibition of neurological disease | |
| WO2022162621A1 (en) | Treatment of sleep apnea with cbd | |
| Atmar et al. | Safety and pharmacokinetics of rimantadine small-particle aerosol | |
| US11660324B2 (en) | Copper complexes for treatment of neurodegenerative disorders | |
| KR20260005781A (ko) | 만성 염증성 탈수초 다발신경병증에 대한 펩타이드의 투여요법 | |
| Parlatescu et al. | Burning mouth syndrome. A case report from diagnosis to cure | |
| Ahmad et al. | Clinical efficacy of Unani herbal formulation in Zeeq-Un-Nafas Shoabi (Bronchial asthma) |